Sign In
Buy MEI
$16.37
-0.300 (-1.80%)
At Close: Aug 10, 2026
Methode Electronics' Board Approves Dividend | MarketScreener
08:06pm, Thursday, 18'th Jun 2020Methode Electronics’ Board Approves Dividend
08:05pm, Thursday, 18'th Jun 2020
CHICAGO, June 18, 2020 -- Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, announced today that.
Analysts Offer Insights on Technology Companies: Axcelis Technologies (NASDAQ: ACLS) and MTBC (NASDAQ: MTBC) - Markets
11:44am, Thursday, 18'th Jun 2020
There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Axcelis Technologies
Analysts' Top Technology Picks: Quantum (QMCO), Kratos Defense (KTOS) - Markets
11:34am, Wednesday, 17'th Jun 2020
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Quantum (QMCO
Methode Electronics, Inc. : annual earnings release | MarketScreener
01:15pm, Monday, 15'th Jun 2020METHODE ELECTRONICS INC : Change in Directors or Principal Officers (form 8-K) | MarketScreener
10:13am, Monday, 15'th Jun 2020Alligator Bioscience Appoints New CFO
09:39am, Monday, 15'th Jun 2020
Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the appointment of Marie Svensson as Chief Financial Officer, CFO. Marie Svensson has more than 20 years of experience from various finan
Methode Electronics, Inc. : publication des résultats annuels | Zone bourse
06:45am, Monday, 15'th Jun 2020Analysts Estimate Methode (MEI) to Report a Decline in Earnings: What to Look Out for
04:30pm, Thursday, 11'th Jun 2020
Methode (MEI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aptevo Therapeutics and Alligator Bioscience Present new Preclinical Data for ALG.APV-527 at the PEGS Virtual Interactive Global Summit
01:39pm, Wednesday, 10'th Jun 2020
Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ bispecific technology platform, and Alliga
Analysts Offer Insights on Technology Companies: Iteris (NASDAQ: ITI), Quantum (NASDAQ: QMCO) and OptimizeRx (NASDAQ: OPRX) - Markets
11:36am, Wednesday, 10'th Jun 2020
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Iteris (ITI
Methode Electronics Inc. (NYSE:MEI) Shares Sold by JPMorgan Chase & Co.
06:14am, Wednesday, 10'th Jun 2020
JPMorgan Chase & Co. reduced its position in Methode Electronics Inc. (NYSE:MEI) by 8.1% in the 1st quarter, HoldingsChannel.com reports. The firm owned 421,061 shares of the electronics maker’s sto
Alligator Bioscience (Nasdaq Stockholm: ATORX) and Scandion Oncology (Spotlight, Sweden: SCOL), today announced signing of a collaboration agreement. The two companies have agreed to explore the anti-
Alligator Bioscience's Collaboration With Biotheus Inc. Proceeds and Second Payment is Received
11:50am, Monday, 01'st Jun 2020
Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the company received an additional USD 0.5 million in a second installment of the upfront payment from the Chinese company Biotheus
Alligator Bioscience Presents Novel Supportive Phase I Data at ASCO for its CTLA-4 x OX40 Bispecific Drug Candidate ATOR-1015
12:13pm, Friday, 29'th May 2020
Alligator Bioscience (Nasdaq Stockholm: ATORX), announces that the company today presents additional novel data from the ongoing Phase I clinical trial with the bispecific drug candidate ATOR-1015 dev
